Key result
Dobutamine-based medical management improves LVEF to 45% in severe LV dysfunction.
Why the study?
Peripartum cardiomyopathy is a rare heart failure with unknown etiology and high fatality, requiring early diagnosis and treatment to improve outcomes.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
May support dobutamine for reversible severe LV dysfunction in select cases; hypothesis-generating and should not yet change practice.
Peripartum cardiomyopathy (PPCM) is a rare form of heart failure with a reported Incidence of 1 per3000 to 1 per 4000 live births and a fatality rate of 20 -50%.Onset is usually between the last month of pregnancy and up to 5 months postpartum in previously healthy women.Although viral autoimmune and idiopathic factors may be contributory, its etiology remains unknown.PPCM is usually presents with signs and symptoms of congestive heart failure.Early diagnosis is important and effective treatment reduces mortality rates and increases the chance of complete recovery of ventricular systolic function.
No takes yet. Share an insight, caveat, or question.
Sowjanya et al. (2015) conducted a case report in Peripartum cardiomyopathy (n=1). Medical management (dobutamine infusion and supportive care) was evaluated on Improvement in left ventricular ejection fraction.
Synapse has enriched 10 related papers. Consider them for comparative context: